30 Years of Evidence

Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.

Image-Guided Robotic Radiosurgery for Trigeminal Neuralgia

Romanelli P, Conti A, Bianchi L, Bergantin A, Martinotti A, Beltramo G | Neurosurgery | 2018

Cyberknife Radiosurgery for Trigeminal Neuralgia

Romanelli P, Conti A, Redaelli I, Martinotti AS, Bergantin A, Bianchi LC, Beltramo G | Cureus | 2019

Factors affecting outcome in frameless non-isocentric stereotactic radiosurgery for trigeminal neuralgia: a multicentric cohort study

Conti A, Acker G, Pontoriero A, Hardt J, Kluge A, Cacciola A, Iatì G, Kufeld M, Budach V, Vajkoczy P, Beltramo G, Pergolizzi S, Bergantin A, Loebel F, Parisi S, Senger C, Romanelli P | Radiat Oncol | 2020

A comparison of dosimetric and clinical parameters between different IMRT boost techniques in preoperative rectal cancer

Karaca S, Aysenur Arli Karacam K | J BUON | 2021

A comparative planning study of step-and-shoot IMRT versus helical tomotherapy for whole-pelvis irradiation in cervical cancer

Chitapanarux I, Tharavichitkul E, Nobnop W, Wanwilairat S, Vongtama R, Traisathit P | J Radiat Res | 2015

Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report

Cordoba A, Nickers P, Tresch E, Castelain B, Leblanc E, Narducci F, Le Tinier F, Lesoin A, Lacornerie T, Lartigau E | Rep Pract Oncol Radiother | 2015

Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study

Arians N, Kieser M, Benner L, Rochet N, Schröder L, Katayama S, Herfarth K, Schubert K, Schneeweiss A, Sohn C, Lindel K, Debus J | Radiat Oncol | 2019

Comparing efficacy of high-dose rate brachytherapy versus helical TomoTherapy in the treatment of cervical cancer

Kim S, Lee S, Hong JH, Park YJ, Song JY, Lee JK, Lee NW | J Gynecol Oncol | 2020

Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer

Mukai Y, Minagawa Y, Inoue H, Sato A, Matsui K, Fukuda T, Onuma K, Hongo H, Shirata R, Nagata H, Hashimoto H, Inoue T, Hata M, Omura M | In Vivo | 2020

Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity

Zhang G, He F, Miao L, Wu H, Zhang Y, Fu C | Jpn J Clin Oncol | 2021

Efficacy of helical tomotherapy combined with CT-guided three-dimensional intracavitary brachytherapy in treatment of locally advanced cervical cancer

Ye X, Ye P, Zheng Y, Xia W | J BUON | 2021

The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between TomoTherapy and volumetric modulated arc therapy

Cheng YK, Kuo SH, Yen HH, Wu JH, Chen YC, and Huang MY | Radiat Oncol | 2022

Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and TomoTherapy for advanced cervical cancer

Li D, Wang D, Feng S, Chen Q, Sheng X, Jia J, Yan X, Zhu J, and Yin Y | Oncol Lett | 2022

High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes

Tomita N, Soga N, Ogura Y, Hayashi N, Kageyama T, Ito M, Koide Y, Yoshida M, Kimura K, Makita C, Tachibana H, Kodaira T | J Cancer Res Clin Oncol | 2016

Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study

Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell’Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C | Clin Oncol | 2016